These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7511284)
1. [Value of cytometric parameters the planning of therapy of urothelial carcinoma]. Taubert G; Rassler J; Nenning H; Rose S Verh Dtsch Ges Pathol; 1993; 77():216-21. PubMed ID: 7511284 [TBL] [Abstract][Full Text] [Related]
2. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder. Nenning H; Rassler J; Minh DH; Stolzenburg JU Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956 [TBL] [Abstract][Full Text] [Related]
3. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder. Fossä SD Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320 [TBL] [Abstract][Full Text] [Related]
4. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder]. Maier G; Heissler HE; Blech M; Schröter W Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050 [TBL] [Abstract][Full Text] [Related]
5. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620 [TBL] [Abstract][Full Text] [Related]
6. [Transitional carcinoma of the bladder. Evaluation of prognostic factors]. Fodor M; Alonso E; Bellotti M; Elsner B; Aparisi I; Pisilli L Medicina (B Aires); 1993; 53(5):413-8. PubMed ID: 7646600 [TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry. Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058 [TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer. Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914 [TBL] [Abstract][Full Text] [Related]
10. DNA-variations in neighbouring epithelium in patients with bladder carcinoma. Foss SD Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):603-10. PubMed ID: 920179 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. Bittard H; Lamy B; Billery C J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280 [TBL] [Abstract][Full Text] [Related]
12. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells. Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971 [TBL] [Abstract][Full Text] [Related]
13. DNA-malignancy-grading of bladder tumor and its clinical significance. Wang XZ; Ma YJ; Zheng JF; Qin HY Chin Med J (Engl); 1992 Oct; 105(10):856-9. PubMed ID: 1291205 [TBL] [Abstract][Full Text] [Related]
14. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma. Kamel MH; Daly PJ; Khan MF; Kay EW; O'Kelly P; Hickey DP Eur J Surg Oncol; 2006 Dec; 32(10):1139-43. PubMed ID: 16784833 [TBL] [Abstract][Full Text] [Related]
15. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341 [TBL] [Abstract][Full Text] [Related]
17. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E; Iborra I; Rubio J; Casanova J; Almenar S BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101 [TBL] [Abstract][Full Text] [Related]
18. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology. Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894 [TBL] [Abstract][Full Text] [Related]
19. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder. Raitanen MP; Tammela TL Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]